A program providing fruit and vegetable prescriptions for diabetes management
Official title: A Pilot, 3-arm Randomized Controlled Trial of a Fruit and Vegetable Prescription Program for Patients With Type Two Diabetes
Run by Milton S. Hershey Medical Center · NCT06107816 · Data updated 2026-11-12
This study is testing whether giving low-income Hispanic adults with Type 2 diabetes vouchers for fruits and vegetables, along with diabetes education, can help them manage their condition better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Locations | 1 site (Reading, Pennsylvania) |
| Status | Recruiting |
| Started | July 26, 2024 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT06107816 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are low-income Hispanic adults diagnosed with Type 2 Diabetes Mellitus for at least six months and with an A1c level of 7% or higher.
✕Probably not a fit
Patients who have recently participated in similar programs or who have uncontrolled mental illness or substance abuse issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program aims to improve diabetes management among Hispanic adults by providing vouchers for fruits and vegetables (F&V) through a prescription model. It targets patients with Type 2 Diabetes Mellitus (T2DM) who are low-income and have not previously engaged in diabetes self-management education. The intervention includes usual care, F&V prescriptions alone, and F&V prescriptions combined with diabetes self-management education and support (DSME/S). The study will assess the impact on dietary intake, glucose control, and program implementation outcomes.
Why it matters
Potential benefit: If successful, this program could significantly improve dietary habits and glucose control in patients with Type 2 Diabetes Mellitus.
How similar studies have gone: Preliminary studies of similar F&V prescription programs have shown positive outcomes, including increased fruit and vegetable intake and reductions in hemoglobin A1c levels.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at Penn State Health St. Joe's Medical Center * Diagnosis of Type 2 Diabetes Mellitus greater than or equal to six months * A1c level is greater than or equal to 7% (53 mmol/mol) * Low income defined as enrolled in Supplemental Nutrition Assistance Program (SNAP), is uninsured or have Medicaid, or identifying as food insecure based on USDA criteria. * Ability to give a blood sample * Willing to respond to contacts from study staff over the study period * Willing and able to give informed consent * Can read and write in English or Spanish Exclusion Criteria: * Diagnosis of Type 2 Diabetes Mellitus less than six months * Patients who have previously participated in the Veggie Rx program in the past year * Patients who have attended any diabetes self-management education and support (DSME/S) sessions in the past year * Women who are pregnant or who plan to become pregnant during the study period * Any uncontrolled mental illness or substance abuse, or inpatient treatment for these in the past six months * Any unstable or significant medical condition in the past 3 months (e.g. recent heart attack, stroke, DVT) * A1c level is less than 7% * Does not speak English or Spanish * Inability to provide informed consent * Unable to give a blood sample
Where it's running
-
Penn State Health St. Joseph Downtown Campus
Reading, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Susan Veldheer, DEd, RD — Penn State College of Medicine
- Study coordinator: Susan Veldheer, DEd, RD
- Email: sveldheer@pennstatehealth.psu.edu
- Phone: 717-531-5625
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MinION sequencing to identify microbes in diabetic foot bone infections
This study will test a rapid MinION DNA sequencing method to identify bacteria, fungi, and resistance genes in infected diabetic foot wounds and compare the results with standard culture.
-
Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers
This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.
-
Optimizing diabetes foot care using eHealth tools
This study is testing a new way to use digital tools to help people with diabetes take better care of their feet and prevent foot ulcers.
-
Using stem cells from fat to treat diabetic foot ulcers
This study is testing if using stem cells from fat, along with a special blood product, can help heal chronic foot ulcers in people with diabetes.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
Measuring bottom-of-foot pressures in people with lateral forefoot amputation due to diabetes
Aiming to see if people with lateral forefoot amputation due to diabetes have higher pressures under remaining foot areas while walking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.